Dr. Reddy's Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Sep 15, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, compliance, foreign-private-issuer
TL;DR
DRL filed a 6-K, confirming 20-F annual reports. Standard compliance filing.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on September 15, 2025, confirming it files annual reports under Form 20-F. The filing is a report of a foreign private issuer.
Why It Matters
This filing indicates Dr. Reddy's compliance with SEC reporting requirements for foreign private issuers, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming reporting status and not indicating any new material events or financial changes.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Registrant
- 0001575872-25-000572 (filing_id) — Accession Number
- 20250915 (date) — Filing Date
- 20250913 (date) — Period of Report
- 1-15182 (sec_file_number) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. It is used to furnish information which the registrant may be required to make public pursuant to the laws of any jurisdiction where it is incorporated or has its principal place of business, or to which it may be required to file with any stock exchange on which its securities are traded.
Which annual report form does Dr. Reddy's Laboratories Limited file?
Dr. Reddy's Laboratories Limited files its annual reports under cover of Form 20-F.
When was this Form 6-K filed?
This Form 6-K was filed on September 15, 2025.
What is the principal executive office address of Dr. Reddy's Laboratories Limited?
The principal executive office address is 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Is Dr. Reddy's Laboratories Limited submitting this Form 6-K in paper format?
The filing does not explicitly state whether it is submitted in paper format, but the standard practice for such filings is electronic submission.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-09-15 06:10:16
Filing Documents
- rdy0802_6k.htm (6-K) — 37KB
- rdy0802_ex99-1.htm (EX-99.1) — 18KB
- rdy0802_ex99-1img01.jpg (GRAPHIC) — 11KB
- rdy0802_ex99-1img02.jpg (GRAPHIC) — 8KB
- 0001575872-25-000572.txt ( ) — 83KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: September 13, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3